CKPT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $48,297.34

Checkpoint Therapeutics Insider Trading History Chart

Checkpoint Therapeutics Share Price & Price History

^$1.42

▼ -0.02 (-1.39%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

Mysterious Gold Leverage Just Announced

From Stansberry Research | Ad

World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.

Find out what it is and see how you can get in with just a few dollars.

Checkpoint Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/28/2024	James F Oliviero III	CEO	Sell	5,894	$2.06	$12,141.64	350,836
2/28/2024	William Garrett Gray	CFO	Sell	2,035	$2.07	$4,212.45	145,224
2/1/2024	James F Oliviero III	CEO	Sell	11,900	$2.01	$23,919.00	369,680
2/1/2024	William Garrett Gray	CFO	Sell	4,115	$1.95	$8,024.25	147,259
3/2/2023	James F Oliviero III	CEO	Sell	5,483	$5.00	$27,415.00	144,090
3/2/2023	William Garrett Gray	CFO	Sell	3,591	$5.00	$17,955.00	51,374
2/27/2023	James F Oliviero III	CEO	Sell	5,548	$4.65	$25,798.20	134,573
2/27/2023	William Garrett Gray	CFO	Sell	1,914	$4.66	$8,919.24	47,465
2/1/2023	James F Oliviero III	CEO	Sell	10,261	$4.77	$48,944.97	182,121
2/1/2023	William Garrett Gray	CFO	Sell	3,154	$4.79	$15,107.66	49,379
1/10/2023	James F Oliviero III	CEO	Sell	3,817	$6.75	$25,764.75	192,382
1/10/2023	William Garrett Gray	CFO	Sell	1,858	$6.75	$12,541.50	52,533
6/23/2022	James F Oliviero III	CEO	Sell	1,500	$11.10	$16,650.00	256,200
6/21/2022	James F Oliviero III	CEO	Sell	2,100	$10.90	$22,890.00	258,900
6/17/2022	James F Oliviero III	CEO	Sell	22,800	$10.90	$248,520.00	261,000
4/13/2022	James F Oliviero III	CEO	Sell	2,125	$15.10	$32,087.50	283,800
4/4/2022	James F Oliviero III	CEO	Sell	8,635	$17.90	$154,566.50	287,329
3/10/2022	William Garrett Gray	CFO	Sell	3,819	$18.90	$72,179.10
2/1/2022	William Garrett Gray	CFO	Sell	3,706	$25.10	$93,020.60

Mysterious Gold Leverage Just Announced

From Stansberry Research | Ad

Find out what it is and see how you can get in with just a few dollars.

SEC Filings (Institutional Ownership Changes) for Checkpoint Therapeutics (NASDAQ:CKPT)

22.00% of Checkpoint Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Checkpoint Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/15/2024	B. Riley Wealth Advisors Inc.	163,350	$0.37M	0.0%	+232.3%	0.694%
2/13/2024	Tower Research Capital LLC TRC	11,174	$26K	0.0%	+92.7%	0.047%
2/13/2024	Armistice Capital LLC	2,426,000	$5.56M	0.1%	+17.5%	10.310%
2/5/2024	Choreo LLC	19,250	$44K	0.0%	N/A	0.082%
2/5/2024	Magnus Financial Group LLC	24,000	$55K	0.0%	N/A	0.102%
12/1/2023	B. Riley Wealth Advisors Inc.	49,150	$84K	0.0%	+9.4%	0.209%
11/15/2023	Sabby Management LLC	205,247	$0.35M	0.3%	N/A	0.951%
11/15/2023	Armistice Capital LLC	2,064,000	$3.51M	0.1%	+46.1%	9.560%
11/1/2023	Legacy Wealth Asset Management LLC	85,000	$0.14M	0.1%	+104.8%	0.394%
10/27/2023	PVG Asset Management Corp	111,025	$0.19M	1.3%	+81.9%	0.514%
10/26/2023	Park Avenue Securities LLC	59,932	$0.10M	0.0%	N/A	0.278%
8/11/2023	D.A. Davidson & CO.	10,000	$25K	0.0%	N/A	0.077%
8/10/2023	Meitav Investment House Ltd.	28,970	$3.68M	0.1%	N/A	0.224%
8/10/2023	Cetera Investment Advisers	15,290	$38K	0.0%	N/A	0.118%
8/4/2023	Legacy Wealth Asset Management LLC	41,500	$0.10M	0.0%	N/A	0.320%
8/4/2023	Apollon Wealth Management LLC	44,429	$0.11M	0.0%	+29.2%	0.343%
7/31/2023	PVG Asset Management Corp	61,025	$0.15M	0.7%	-55.5%	0.471%
7/27/2023	B. Riley Wealth Advisors Inc.	44,945	$0.11M	0.0%	+26.1%	0.347%
7/24/2023	Meitav Investment House Ltd.	28,970	$3.68M	0.1%	N/A	0.224%
5/9/2023	Cowen AND Company LLC	220,000	$0.50M	0.1%	N/A	1.699%
5/8/2023	Emfo LLC	15,715	$35K	0.0%	+101.6%	0.121%
3/15/2023	B. Riley Wealth Advisors Inc.	19,150	$98K	0.0%	-87.8%	0.206%
2/7/2023	Envestnet Asset Management Inc.	27,805	$0.14M	0.0%	-71.0%	0.299%
2/2/2023	Emfo LLC	7,795	$40K	0.0%	-95.9%	0.084%
1/31/2023	Ironwood Investment Management LLC	12,564	$64K	0.0%	-91.0%	0.135%
1/24/2023	Park Avenue Securities LLC	46,545	$0.24M	0.0%	-57.8%	0.500%
1/4/2023	Bartlett & Co. LLC	5,000	$26K	0.0%	-90.0%	0.054%
11/18/2022	Spotlight Asset Group Inc.	661,597	$0.62M	0.6%	N/A	7.114%
11/14/2022	Baader Bank Aktiengesellschaft	88,200	$9.88M	0.8%	N/A	0.095%
11/8/2022	Apollon Wealth Management LLC	129,351	$0.14M	0.0%	+31.9%	0.140%
11/8/2022	Atom Investors LP	68,734	$71K	0.0%	N/A	0.074%
10/21/2022	Morgan Jess S & Co. Inc.	1,894,694	$1.97M	1.7%	+66.6%	2.048%
10/13/2022	PVG Asset Management Corp	392,375	$0.41M	1.6%	N/A	0.424%
8/11/2022	Apollon Wealth Management LLC	98,095	$0.10M	0.0%	+29.5%	0.108%
7/27/2022	Park Avenue Securities LLC	110,176	$0.11M	0.0%	-47.6%	0.121%
7/18/2022	Morgan Jess S & Co. Inc.	1,137,322	$1.17M	1.2%	+3.9%	1.249%
5/16/2022	Morgan Jess S & Co. Inc.	1,094,714	$1.94M	1.4%	-6.9%	1.208%
5/12/2022	Healthcare of Ontario Pension Plan Trust Fund	1,107,100	$1.96M	0.0%	N/A	1.222%
4/29/2022	Park Avenue Securities LLC	210,176	$0.37M	0.0%	+289.2%	0.232%
3/8/2022	Bartlett & Co. LLC	50,000	$0.16M	0.0%	N/A	0.060%
2/15/2022	Mirabella Financial Services LLP	21,700	$67K	0.0%	N/A	0.026%
2/11/2022	Level Four Advisory Services LLC	10,000	$31K	0.0%	N/A	0.012%
2/10/2022	Qube Research & Technologies Ltd	43,444	$0.14M	0.0%	N/A	0.052%
2/10/2022	Paradigm Financial Partners LLC	42,000	$0.12M	0.0%	N/A	0.050%
2/10/2022	Ironwood Investment Management LLC	136,155	$0.42M	0.2%	+3.2%	0.163%
2/9/2022	Alps Advisors Inc.	96,944	$0.30M	0.0%	N/A	0.116%
2/4/2022	Envestnet Asset Management Inc.	66,847	$0.21M	0.0%	+12.0%	0.080%
2/3/2022	Advisor Group Holdings Inc.	98,503	$0.31M	0.0%	+51.4%	0.118%
2/2/2022	PVG Asset Management Corp	80,307	$0.25M	0.9%	-9.9%	0.096%
2/1/2022	Qube Research & Technologies Ltd	43,444	$0.14M	0.0%	N/A	0.052%
1/28/2022	National Asset Management Inc.	96,500	$0.30M	0.0%	-18.9%	0.115%
1/28/2022	Exane Derivatives	31,262	$97K	0.0%	-35.2%	0.037%
1/27/2022	Emfo LLC	196,250	$0.61M	0.5%	-19.4%	0.234%
1/27/2022	Morgan Jess S & Co. Inc.	1,175,832	$3.66M	2.2%	+0.7%	1.404%
12/30/2021	Segall Bryant & Hamill LLC	15,000	$50K	0.0%	N/A	0.018%
11/16/2021	National Asset Management Inc.	119,000	$0.39M	0.0%	+2.6%	0.142%
11/16/2021	Two Sigma Advisers LP	421,400	$1.39M	0.0%	+38.7%	0.509%
11/16/2021	Two Sigma Investments LP	299,832	$0.99M	0.0%	+50.3%	0.362%
11/16/2021	Telemetry Investments L.L.C.	70,000	$0.23M	0.3%	N/A	0.085%
11/16/2021	Millennium Management LLC	838,180	$2.77M	0.0%	-18.3%	1.013%
11/15/2021	Marshall Wace LLP	121,785	$0.40M	0.0%	-52.5%	0.147%
11/15/2021	Capstone Investment Advisors LLC	17,636	$58K	0.0%	N/A	0.021%
11/12/2021	Geode Capital Management LLC	559,964	$1.85M	0.0%	+14.4%	0.677%
11/10/2021	PVG Asset Management Corp	89,127	$0.29M	0.9%	+255.0%	0.108%
11/9/2021	Morgan Jess S & Co. Inc.	1,167,332	$3.85M	2.5%	N/A	1.411%
11/9/2021	Barclays PLC	8,216	$27K	0.0%	-84.4%	0.010%
11/9/2021	BlackRock Inc.	935,175	$3.09M	0.0%	+13.6%	1.130%
11/5/2021	Truist Financial Corp	14,169	$47K	0.0%	+29.2%	0.017%
11/5/2021	Advisor Group Holdings Inc.	65,063	$0.22M	0.0%	+474.9%	0.079%
11/3/2021	Segall Bryant & Hamill LLC	15,000	$50K	0.0%	N/A	0.018%
11/2/2021	Raymond James Financial Services Advisors Inc.	29,000	$96K	0.0%	+43.0%	0.035%
10/26/2021	Cordant Inc.	10,820	$36K	0.0%	N/A	0.013%
10/13/2021	Asset Management Corp IL ADV	85,750	$0.28M	0.1%	-5.5%	0.104%
9/3/2021	Parametric Portfolio Associates LLC	14,697	$43K	0.0%	-32.9%	0.018%
8/26/2021	Y Intercept Hong Kong Ltd	11,966	$35K	0.0%	N/A	0.014%
8/25/2021	Marshall Wace LLP	256,281	$0.76M	0.0%	N/A	0.310%
8/17/2021	PVG Asset Management Corp	25,107	$74K	0.2%	+68.9%	0.030%
8/17/2021	Millennium Management LLC	1,025,432	$3.03M	0.0%	+716.4%	1.239%
8/17/2021	Boothbay Fund Management LLC	14,629	$43K	0.0%	N/A	0.018%
8/16/2021	LMR Partners LLP	30,513	$90K	0.0%	N/A	0.037%
8/16/2021	Cubist Systematic Strategies LLC	13,339	$39K	0.0%	N/A	0.016%
8/16/2021	Charles Schwab Investment Management Inc.	16,943	$50K	0.0%	-86.4%	0.020%
8/16/2021	State Street Corp	192,467	$0.57M	0.0%	-77.4%	0.233%
8/16/2021	Tibra Equities Europe Ltd	116,000	$0.34M	0.1%	N/A	0.140%
8/16/2021	Goldman Sachs Group Inc.	130,091	$0.38M	0.0%	+424.6%	0.157%
8/16/2021	Marshall Wace LLP	256,281	$0.76M	0.0%	N/A	0.310%
8/13/2021	Northern Trust Corp	118,644	$0.35M	0.0%	-77.5%	0.150%
8/13/2021	Qube Research & Technologies Ltd	23,064	$68K	0.0%	N/A	0.029%
8/13/2021	Geode Capital Management LLC	489,414	$1.44M	0.0%	-38.7%	0.618%
8/13/2021	Vanguard Group Inc.	2,583,983	$7.62M	0.0%	+3.1%	3.263%
8/12/2021	XTX Topco Ltd	16,215	$48K	0.0%	+37.0%	0.020%
8/12/2021	Dimensional Fund Advisors LP	11,400	$34K	0.0%	N/A	0.014%
8/12/2021	JPMorgan Chase & Co.	86,296	$0.25M	0.0%	-22.7%	0.109%
8/12/2021	Ergoteles LLC	157,800	$0.47M	0.0%	N/A	0.199%
8/11/2021	Bank of New York Mellon Corp	17,849	$53K	0.0%	-85.2%	0.023%
8/11/2021	BlackRock Inc.	822,860	$2.43M	0.0%	-76.8%	1.039%
8/11/2021	Deutsche Bank AG	67,973	$0.20M	0.0%	-84.8%	0.086%
8/11/2021	Spotlight Asset Group Inc.	661,597	$1.95M	0.8%	+1.5%	0.836%
8/10/2021	National Asset Management Inc.	116,000	$0.34M	0.0%	+27.5%	0.146%
8/6/2021	Asset Management Corp IL ADV	90,750	$0.27M	0.2%	N/A	0.115%

Data available starting January 2016

Checkpoint Therapeutics, Inc., a clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally. The company's lead antibody product candidate is Cosibelimab, which is in Phase 1 clinical trial to treat patients with selected recurrent or metastatic cancers; and CK-302, a product candidate in preclinical trials for hematological malignancies and solid tumors. It is also developing Olafertinib, which is in Phase 3 clinical trials for the treatment of adult patients with metastatic non-small cell lung cancer; CK-103 for the treatment of various advanced and metastatic solid tumor cancers; and Anti-Carbonic Anhydrase IX (CAIX) antibody, a product candidate in preclinical trials to recognize CAIX expressing cells and kill them via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. The company has licensing and collaboration agreements with Adimab, LLC for the development of Cosibelimab; NeuPharma, Inc., to develop and commercialize Olafertinib; and Jubilant Biosys Limited for the development and commercialization of novel compounds that inhibit BET bromodomains. The company was incorporated in 2014 and is based in Waltham, Massachusetts. Checkpoint Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.

Today's Range

Now: $1.42

$1.41

$1.50

50 Day Range

MA: $1.92

$1.44

$2.32

52 Week Range

Now: $1.42

$1.30

$3.62

Volume

166,048 shs

Average Volume

532,797 shs

Market Capitalization

$50.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.99

Who are the company insiders with the largest holdings of Checkpoint Therapeutics?: Checkpoint Therapeutics' top insider investors include:
James F Oliviero III (CEO)
William Garrett Gray (CFO)
Learn More about top insider investors at Checkpoint Therapeutics.